Abstract
Rationale
There is a broad range of complex ethical issues in the conduct of psychopharmacological drug studies that go beyond the question of the ethics of placebo controls. However, our empirical knowledge with respect to these issues is very limited. This review, although not exhaustive, highlights an array of ethical issues that arose from discussions within the NIMH Human Subjects Research Council Workgroup.
Objectives
To delineate issues in psychopharmacological drug studies that require debate and would benefit from research leading to the development of empirically-supported guidelines.
Methods
Information included in this report was drawn from the first author's participation as chair of the NIMH Human Subjects Research Council Workgroup, guidelines for the ethical conduct of research proposed by professional organizations to which the first and third author belong, and relevant research literature.
Results
We have focused on general issues relating to informed consent, research with special populations, and long-term treatment studies. Additionally, we raise issues relevant to large research-oriented institutions.
Conclusions
The essential ethical challenge in psychopharmacological trials is to balance risks and benefits in the context of the needs and capacities of individual research subjects. The IRB system must become evidence-based and not rely on unproven assumptions. Specific research studies should be undertaken to address many of the issues of informed consent and research ethics postulated in this paper.
Similar content being viewed by others
References
Altshuler LL, Hendrick V, Cohen LS (1998) Course of mood and anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry 59:29–33
Altshuler LL, Cohen LS, Moline ML, Kahn DA, Carpenter D, Docherty JP (2001) Treatment of depression in women: a summary of the expert consensus guidelines. J Psychiatr Pract 7:185–208
American College of Neuropsychopharmacology (2001) A statement of principles of ethical conduct for neuropsychopharmacologic research in human subjects. In: Directory of Members 2001. ACNP, Nashville, pp 225–238
American Psychiatric Association (1993) Clinical practice guidelines for MDD in adults. Am J Psychiatry 150:15–16
Angst J, Sellaro R (2000) Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 48:445–457
Annas GJ (2001) Reforming informed consent to genetic research. JAMA 286:2326-2328
Appelbaum PS, Grisso T (1995) The MacArthur treatment competence study I, II, III. Law Hum Behav 19:105–174
Appelbaum PS, Grisso T, Frank E, O'Donnell S, Kupfer DJ (1999) Competence of depressed patients for consent to research. Am J Psychiatry 156:1380–1384
Avins AL (1998) Can unequal be more fair? Ethics, subject allocation, and randomized clinical trials. J Med Ethics 24:401–408
Carpenter WT, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS (2000) Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry 57:533–538
Daugherty C, Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R, Siegler M (1995) Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 13:1062–1072
D'Souza DC, Krystal JH (2001) Psychopharmacological challenge studies in psychiatric research. Int Rev Psychiatry 13:40–46
Food and Drug Administration: Department of Health and Human Services (1993) Guidelines for the study and evaluation of gender differences in the clinical evaluation of drugs (Docket No. 93D-0236). Washington, D.C.
Foucar E (2001) How much oversight is necessary to protect human subjects? JAMA 287:716–717
Fowles ER (1998) The relationship between maternal role attainment and postpartum depression. Health Care for Women International 19:83–94
Gaylin W (1982) The competence of children: no longer all or none. Hastings Center Report 12:33–38
Grahnke L (1999) UIC head resigns. Chicago Sun Times, November 9
Grush LR, Cohen LS (1998) Treatment of depression during pregnancy: balancing the risks. Harv Rev Psychiatry 6:105–109
Heath AC, Yonkers KA (2001) Somatic treatments in depression: Concerns during pregnancy and breastfeeding. In: Yonkers K, Little B (eds) Management of psychiatric disorders in pregnancy. Oxford University Press, New York, pp 82–104
Kantor JE (1994) Ethical issues in psychiatric research and training. In: Oldham JM, Riba MB (eds) Annual review of psychiatry, vol 13. American Psychiatric Press, Washington D.C., pp 33–342
Kaplan S, Brownlee S (1999) Dying for a cure. US News and World Report, October 11
Katz J (1997) Human sacrifice and human experimentation: reflections at Nuremberg. Yale Law School Occasional Papers 2:16–17
Llewellyn AM, Stowe ZN, Nemeroff CB (1997) Depression during pregnancy and the puerperium. J Clin Psychiatry 58:26–32
Masand PD, Gupta S (1999) SSRIs: an update. Harv Rev Psychiatry 7:69-84
Misri S, Kostaras D, Kostaras X (2000) The use of SSRIs during pregnancy and lactation: current knowledge. Can J Psychiatry 45:285–287
Munir K, Earls F (1992) Ethical principles governing research in child and adolescent psychiatry. J Am Acad Child Adolesc Psychiatry 31:408-414
National Bioethics Advisory Commission (2001) Ethical and policy issues in research involving human participants. Bethesda, Md.
National Institute of Health (2002) Bioethics resources on the Web [on-line]. Available: http://www.nih.gov/sigs/bioethics/IRB.html
National Research Council (1997) For the record: protecting electronic health information. National Academy of Sciences, Washington, D.C.
Office for Human Research Protection (2002) IRB guidebook (on-line). Available: http://ohrp.osophs.dhhs.gov/irb/irb_guidebook.htm
Ondrusek N, Abramovitch R, Pencharz P, Koren G (1998) Empirical examination of the ability of children to consent to clinical research. J Med Ethics 24:158–165
Paul M, Foreman DM, Kent L (2000) Outpatient clinic attendance: consent from children and young people—ethical aspects and practical considerations. Clin Child Psychol Psychiatry 5:203–211
Quitkin FM (1999) Placebos, drug effects, and study design: a clinician's guide. Am J Psychiatry 156:829–836
Roberts LW, Warner TD, Brody JL (2000) Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation. Am J Psychiatry 157:67–74
Roberts LW, Geppert C, Brody JL (2001a) A framework for considering the ethical aspects of psychiatric research protocols. Com Psychiatry 42:351-363
Roberts LW, Lauriello J, Geppert C, Keith SJ (2001b) Placebos and paradoxes in psychiatric research: an ethics perspective. Biol Psychiatry 49:887–893
Roberts LW, Warner TD, Brody JL, Roberts B, Lauriello J, Lyketsos C (2003) Research harm assessments and participation decisions of schizophrenia. Am J Psychiatry (in press)
Schaefer A (1982) The ethics of the randomized clinical trial. N Engl J Med 307:719–725
Shalala D (2000) Protecting research subjects—what must be done. N Engl J Med 343:808–810
Spiro HM (1986) Mammon and medicine: the rewards of clinical trials. JAMA 255:1174-1175
US Congress, Office of Technology Assessment, Mental Disorders and Genetics (1994) Bridging the gap between research and society (publication no. OTA-BP-H133). US Government Printing Office, Washington, D.C.
Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ (2000) Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 157:179–184
Weissman M, Jensen P (2000) What research suggests for depressed women with children. Paper presented for the Treatment and Prevention/Targeted Population Section of the Summit on Women and Depression, Queenstown, Md.
Weissman MM, Warner V, Wickramaratne P, Moreau D, Olfson M (2001) Offspring at risk: early onset major depression and anxiety disorders over a decade. In: Rapoport JL (ed) Childhood onset of "adult" psychopathology: clinical and research advances. American Psychopathological Association Series, Washington, D.C., pp 245–258
Wendler D (2000) Informed consent, exploitation and whether it is possible to conduct human subjects research without either one. Bioethics 14:310–339
Wisner KL, Perel JM (1988) Psychopharmacologic agents and electroconvulsive therapy during pregnancy and the puerperium. In: Cohen RL (ed) Psychiatric consultation in childbirth settings: parent- and child-oriented approaches. Plenum, New York, pp 165–206
Wisner KL, Perel JM, Peindl KS, Gracious BL (2000) Depression during pregnancy and the postpartum period. Paper presented for the Treatment and Prevention/Targeted Population Section of the Summit on Women and Depression. Queenstown, Md.
Acknowledgements
This research was supported, in part, by National Institute of Mental Health grants MH29618 (Dr. Frank), MH30915 (Drs. Kupfer and Frank). The first author also acknowledges the multiple contributions to this report that arose from discussions with Drs. Charles Nemeroff, A. John Rush, Robert Levine, Laura Roberts, Arthur Kaplan, Paul Weaver and Mr. James McNulty, all members of the NIMH Human Subjects Research Council Workgroup and Dr. David Shore who staffed the Workgroup.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Frank, E., Novick, D.M. & Kupfer, D.J. Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies. Psychopharmacology 171, 19–26 (2003). https://doi.org/10.1007/s00213-003-1477-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-003-1477-z